Tissue inhibitor of metalloproteinase-1 (TIMP-1) is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction
Open Access
- 31 May 2006
- journal article
- Published by Elsevier BV in American Heart Journal
- Vol. 151 (5), 1101.e1-1101.e8
- https://doi.org/10.1016/j.ahj.2006.02.029
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Different expression of MMPs/TIMP-1 in human atherosclerotic lesions. Relation to plaque features and vascular bedAtherosclerosis, 2003
- Reduced Atherosclerotic Plaque but Enhanced Aneurysm Formation in Mice With Inactivation of the Tissue Inhibitor of Metalloproteinase-1 ( TIMP-1 ) GeneCirculation Research, 2002
- Matrix Metalloproteinases in Vascular Remodeling and AtherogenesisCirculation Research, 2002
- Cytomegalovirus Infection With Interleukin-6 Response Predicts Cardiac Mortality in Patients With Coronary Artery DiseaseCirculation, 2001
- Tissue inhibitors of metalloproteinases: evolution, structure and functionBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 2000
- Tissue inhibitors of metalloproteases: Regulation and biological activitiesClinical & Experimental Metastasis, 2000
- Identification of 92-kD Gelatinase in Human Coronary Atherosclerotic LesionsCirculation, 1995
- Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.JCI Insight, 1994
- Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion.Circulation Research, 1994
- The induction of 72-kD gelatinase in T cells upon adhesion to endothelial cells is VCAM-1 dependent.The Journal of cell biology, 1994